The difference between U.S. federal marijuana laws and the legal framework in many states around the country has created an ironical situation in which everyone can easily access marijuana in state-legal and states where cannabis is still illegal, but scientists who desperately need high-quality cannabis for research purposes cannot get it.
This situation is very frustrating for the scientists because they know that the private sector in states where cannabis is legal has made available cannabis of very high quality, but scientists can’t lay a finger on it due to federal restrictions.
Instead, the scientists are made to jump through endless hoops in order to get an often inadequate supply of cannabis from the Mississippi University facility authorized to grow cannabis for research purposes.
That cannabis is so inferior in quality that it would never get a buyer if it was put on the open market and buyers compared it to what is available for medical or recreational use in jurisdictions where cannabis is legal.
It is also disturbing that the federal authorities claim that there isn’t sufficient research to back the claims that cannabis is medicinal, and yet the very authorities have made it hard for cannabis research to be conducted. In essence, a catch-22 situation has developed.
These legal roadblocks aren’t likely to end soon, given that the two houses (Congress and the Senate) are unlikely to agree on anything related to marijuana since one is largely Democrat while the other is controlled by Republicans who are renowned for their opposition to any reforms aimed at relaxing cannabis laws.
However, not all is lost. The federal government recently invited qualified entities to apply and grow cannabis for the different research programs that will be approved in 2019. This may break the monopoly held by Mississippi University, but it may not be time to celebrate just yet because issues of quality may still arise in case the selected firms don’t come with the mindset that what they produce must be at par with what the commercial entities are providing to the public.
The other factor that brings hope is the passing of the 2018 Farm Bill. With hemp now legal, it is likely to get easier to study cannabinoids since hemp also contains some limited amounts of THC. The feds may therefore be compelled to ease restrictions since the people studying CBD will also be interested in looking at THC and other cannabinoids.
The entire cannabis industry, including FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) and Earth Science Tech, Inc. (OTCQB: ETST) long for the time when the scientific community in the U.S. will find it as easy to get cannabis for research reasons as ordinary people get the product for medical or recreational use.
More from CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com